Menu Menu


GLAXF Financials       Clear


GLAXF        0001131399    
Filing Date Form Type Description Document
2021-05-17 6-K SANOFI/GSK COVID-19 VACCINE POSITIVE PH2 RESULTS View Document
2021-05-14 25-NSE View Document
2021-05-13 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-05-11 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-05-11 6-K EMTN PROSPECTUS View Document
2021-05-06 6-K BOARD AND COMMITTEE CHANGES View Document
2021-05-05 6-K RESULT OF AGM View Document
2021-05-04 6-K TOTAL VOTING RIGHTS View Document
2021-04-28 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-04-28 6-K 1ST QUARTER RESULTS View Document
2021-04-26 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-04-23 6-K EU APPROVES GSK'S JEMPERLI (DOSTARLIMAB-GXLY) View Document
2021-04-23 6-K FDA APPROVES GSK'S JEMPERLI (DOSTARLIMAB-GXLY) View Document
2021-04-16 SC 13D/A AMENDMENT TO FORM SC 13D View Document
2021-04-16 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-04-15 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-04-15 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-04-14 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-04-14 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-04-12 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-04-12 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-04-09 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-04-09 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-04-08 SC 13D/A AMENDMENT TO FORM SC 13D View Document
2021-04-06 6-K DIRECTORATE CHANGE View Document
2021-04-01 6-K TOTAL VOTING RIGHTS View Document
2021-03-30 6-K PUBLICATION OF 2021 AGM NOTICE View Document
2021-03-30 6-K GSK RESPIRATORY PRODUCT SALES REPORTING CHANGES View Document
2021-03-26 F-3ASR F-3ASR View Document
2021-03-24 6-K MONCEF SLAOUI DEPARTS GALVANI BIOELECTRONICS View Document
2021-03-23 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-03-17 6-K CHAIR OF AUDIT & RISK COMMITTEE View Document
2021-03-16 6-K MEDICAGO AND GSK START PHASE 3 TRIAL View Document
2021-03-15 F-6 POS View Document
2021-03-15 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-03-15 6-K ANNUAL REPORT 2020 ON FORM 20-F View Document
2021-03-12 IRANNOTICE IRANNOTICE View Document
2021-03-12 20-F 20-F View Document
2021-03-11 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-03-11 6-K GSK AND VIR SHARE POSITIVE VIR-7831 DATA IN COVID View Document
2021-03-10 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-03-09 6-K ANNUAL FINANCIAL REPORT View Document
2021-03-02 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-03-01 6-K TOTAL VOTING RIGHTS View Document
2021-02-25 6-K GSK ANNOUNCES OTILIMAB DATA FOR TREATMENT OF COVID View Document
2021-02-24 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-02-24 6-K HOLDING(S) IN COMPANY View Document
2021-02-23 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-02-22 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-02-22 6-K SANOFI AND GSK INITIATE NEW PHASE 2 STUDY View Document
2021-02-19 4 CHANGES IN BENEFICIAL OWNERSHIP View Document
2021-02-19 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-02-19 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-02-19 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-02-18 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-02-17 6-K GSK/VIR COLLABORATE ON ANTIBODIES FOR INFLUENZA View Document
2021-02-17 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-02-16 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-02-16 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-02-12 SC 13D/A AMENDMENT TO FORM SC 13D View Document
2021-02-12 SC 13G/A AMENDMENT TO FORM SC 13G View Document
2021-02-12 SC 13G/A AMENDMENT TO FORM SC 13G View Document
2021-02-12 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-02-12 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-02-12 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-02-11 3 OWNERSHIP DOCUMENT View Document
2021-02-10 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-02-10 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-02-04 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-02-03 6-K FINAL RESULTS View Document
2021-02-03 6-K GSK/CUREVAC PARTNER ON NEW MRNA COVID-19 VACCINES View Document
2021-02-01 6-K TOTAL VOTING RIGHTS View Document
2021-01-29 SC 13G/A View Document
2021-01-26 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-01-22 6-K FDA APPROVES VIIV HEALTHCARE'S CABENUVA FOR HIV View Document
2021-01-20 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-01-20 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-01-20 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-01-19 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-01-19 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-01-15 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-01-15 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-01-13 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-01-11 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-01-11 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-01-04 6-K TOTAL VOTING RIGHTS View Document
2020-12-30 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-12-23 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-12-21 6-K VIIV FIRST LONG-ACTING HIV REGIMEN APPROVED IN EU View Document
2020-12-11 6-K SANOFI/ GSK UPDATE ON COVID VACCINE CANDIDATE View Document
2020-12-10 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-12-10 6-K BLOCK LISTING APPLICATION View Document
2020-12-09 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-12-07 SC 13D/A AMENDMENT NO. 5 TO SC 13D View Document
2020-12-07 SC 13D/A AMENDMENT NO. 2 TO SC 13D View Document
2020-12-03 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-12-01 6-K TOTAL VOTING RIGHTS View Document
2020-11-30 SC 13G ACQUISITION OF BENEFICIAL OWNERSHIP View Document
2020-11-27 6-K GSK PUBLISHES PROVISIONAL 2021 DIVIDEND DATES View Document
2020-11-27 6-K EMTN SUPPLEMENTARY PROSPECTUS View Document

Find registration statements, periodic reports, and other forms by typing ticker symbol of a company.

Ticker:

Search company filings and access detailed reports including 10-K, 10-Q, 8-K, and other critical filings. Stay informed on corporate disclosures, regulatory filings, and updates with our easy-to-use EDGAR API filings search tool.



We can also help with your taxes.

Formal Tax

www.formal.tax





(402) 804-8293


Formal Financial App
Google Play - Apple Store

created using: Admin Canvas